A dual chicken IgY against rotavirus and norovirus

Antiviral Research

Volumn 97, Issue 3, 2013, Pages 293-300

  Dai, Ying Chun ^a,b   Zhang, Xu Fu ^a,b   Tan, Ming ^b,c   Huang, Pengwei ^b   Lei, Wen ^b   Fang, Hao ^b   Zhong, Weiming ^b   Jiang, Xi ^b,c  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Diarrhea; Immunoglobulin Y (IgY); Norovirus; Passive immunization; Rotavirus

Indexed keywords

IMMUNOGLOBULIN Y;

ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; IMMUNOGENICITY; INOCULATION; NONHUMAN; NOROVIRUS; PRIORITY JOURNAL; ROTAVIRUS; VIRUS NEUTRALIZATION; VIRUS PARTICLE; VIRUS REPLICATION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, VIRAL; CALICIVIRIDAE INFECTIONS; CHICKENS; HUMANS; IMMUNOGLOBULINS; NOROVIRUS; ROTAVIRUS; ROTAVIRUS INFECTIONS; VIRAL VACCINES;

GALLUS GALLUS; NOROVIRUS; ROTAVIRUS;

EID: 84873037956     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2012.12.011     Document Type: Article

References (36)

1. Chalghoumi R., Beckers Y., Portetelle D., Thewis A. Hen egg yolk antibodies (IgY), production and use for passive immunization against bacterial enteric infections in chicken: a review. Biotechnol. Agron Soc. 2009, 13:295-308.
2. Chalghoumi R., Marcq C., Thewis A., Portetelle D., Beckers Y. Effects of feed supplementation with specific hen egg yolk antibody (immunoglobin Y) on Salmonella species cecal colonization and growth performances of challenged broiler chickens. Poult. Sci. 2009, 88:2081-2092.
3. Dai Y.C., Wang Y.Y., Zhang X.F., Tan M., Xia M., Wu X.B., Jiang X., Nie J. Evaluation of anti-norovirus IgY from egg yolk of chickens immunized with norovirus P particles. J. Virol. Methods 2012, 186:126-131.
4. de Paula V.S., da Silva Ados S., de Vasconcelos G.A., Iff E.T., Silva M.E., Kappel L.A., Cruz P.B., Pinto M.A. Applied biotechnology for production of immunoglobulin Y specific to hepatitis A virus. J. Virol. Methods 2011, 171:102-106.
5. Gauthier M.S., O'Brien E.L., Bigornia S., Mott M., Cacicedo J.M., Xu X.J., Gokce N., Apovian C., Ruderman N. Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans. Biochem. Biophys. Res. Commun. 2011, 404:382-387.
6. Glass R.I., Bresee J., Jiang B., Gentsch J., Ando T., Fankhauser R., Noel J., Parashar U., Rosen B., Monroe S.S. Gastroenteritis viruses: an overview. Novartis Found. Symp. 2001, 238:5-19. (discussion 19-25).
7. Glass R.I., Parashar U.D., Estes M.K. Norovirus gastroenteritis. N. Engl. J. Med. 2009, 361:1776-1785.
8. * of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature 2012, 485:256-259.
9. Huang P., Farkas T., Marionneau S., Zhong W., Ruvoen-Clouet N., Morrow A.L., Altaye M., Pickering L.K., Newburg D.S., LePendu J., Jiang X. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J. Infect. Dis. 2003, 188:19-31.
10. Huang P., Farkas T., Zhong W., Tan M., Thornton S., Morrow A.L., Jiang X. Norovirus and histo-blood group antigens: demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J. Virol. 2005, 79:6714-6722.
11. * of human rotavirus recognizes histo-blood group antigens in a type-specific manner. J. Virol. 2012, 86:4833-4843.
12. Keller M.A., Stiehm E.R. Passive immunity in prevention and treatment of infectious diseases. Clin. Microbiol. Rev. 2000, 13:602-614.
13. Kovacs-Nolan J., Mine Y. Microencapsulation for the gastric passage and controlled intestinal release of immunoglobulin Y. J. Immunol. Methods 2005, 296:199-209.
14. Kovacs-Nolan J., Yoo D., Mine Y. Fine mapping of sequential neutralization epitopes on the subunit protein VP8 of human rotavirus. Biochem. J. 2003, 376:269-275.
15. Li X.Y., Jin L.J., Uzonna J.E., Li S.Y., Liu J.J., Li H.Q., Lu Y.N., Zhen Y.H., Xu Y.P. Chitosan-alginate microcapsules for oral delivery of egg yolk immunoglobulin (IgY): in vivo evaluation in a pig model of enteric colibacillosis. Vet. Immunol. Immunopathol. 2009, 129:132-136.
16. Liou J.F., Chang C.W., Tailiu J.J., Yu C.K., Lei H.Y., Chen L.R., Tai C. Passive protection effect of chicken egg yolk immunoglobulins on enterovirus 71 infected mice. Vaccine 2010, 28:8189-8196.
17. Nguyen H.H., Tumpey T.M., Park H.J., Byun Y.H., Tran L.D., Nguyen V.D., Kilgore P.E., Czerkinsky C., Katz J.M., Seong B.L., Song J.M., Kim Y.B., Do H.T., Nguyen T., Nguyen C.V. Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice. PLoS ONE 2010, 5:e10152.
18. Nurminen K., Blazevic V., Huhti L., Rasanen S., Koho T., Hytonen V.P., Vesikari T. Prevalence of norovirus GII-4 antibodies in Finnish children. J. Med. Virol. 2011, 83:525-531.
19. Parashar U.D., Hummelman E.G., Bresee J.S., Miller M.A., Glass R.I. Global illness and deaths caused by rotavirus disease in children. Emerg. Infect. Dis. 2003, 9:565-572.
20. Patel M., Shane A.L., Parashar U.D., Jiang B., Gentsch J.R., Glass R.I. Oral rotavirus vaccines: how well will they work where they are needed most?. J. Infect. Dis. 2009, 200(Suppl 1):S39-48.
21. Patel N.C., Hertel P.M., Estes M.K., de la Morena M., Petru A.M., Noroski L.M., Revell P.A., Hanson I.C., Paul M.E., Rosenblatt H.M., Abramson S.L. Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N. Engl. J. Med. 2010, 362:314-319.
22. Patterson R., Youngner J.S., Weigle W.O., Dixon F.J. Antibody production and transfer to egg yolk in chickens. J. Immunol. 1962, 89:272-278.
23. Pauly D., Chacana P.A., Calzado E.G., Brembs B., Schade R. IgY technology: extraction of chicken antibodies from egg yolk by polyethylene glycol (PEG) precipitation 2011, J. Vis. Exp.
24. Reeck A., Kavanagh O., Estes M.K., Opekun A.R., Gilger M.A., Graham D.Y., Atmar R.L. Serological correlate of protection against norovirus-induced gastroenteritis. J. Infect. Dis. 2010, 202:1212-1218.
25. Schwartz S., Vergoulidou M., Schreier E., Loddenkemper C., Reinwald M., Schmidt-Hieber M., Flegel W.A., Thiel E., Schneider T. Norovirus gastroenteritis causes severe and lethal complications after chemotherapy and hematopoietic stem cell transplantation. Blood 2011, 117:5850-5856.
26. Tan M., Fang P., Chachiyo T., Xia M., Huang P., Fang Z., Jiang W., Jiang X. Noroviral P particle: structure, function and applications in virus-host interaction. Virology 2008, 382:115-123.
27. Tan M., Huang P., Xia M., Fang P.A., Zhong W., McNeal M., Wei C., Jiang W., Jiang X. Norovirus P particle, a novel platform for vaccine development and antibody production. J. Virol. 2011, 85:753-764.
28. Tan M., Jiang X. The p domain of norovirus capsid protein forms a subviral particle that binds to histo-blood group antigen receptors. J. Virol. 2005, 79:14017-14030.
29. Tan M., Jiang X. Norovirus P particle, a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus. Nanomedicine 2012, 7:1-9.
30. Tate J.E., Burton A.H., Boschi-Pinto C., Steele A.D., Duque J., Parashar U.D. 2008 estimate of worldwide rotavirus-associated mortality in children younger than 5years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect. Dis. 2012, 12:136-141.
31. Vega C., Bok M., Chacana P., Saif L., Fernandez F., Parreno V. Egg yolk IgY: protection against rotavirus induced diarrhea and modulatory effect on the systemic and mucosal antibody responses in newborn calves. Vet. Immunol. Immunopathol. 2011, 142:156-169.
32. Wallach M.G., Webby R.J., Islam F., Walkden-Brown S., Emmoth E., Feinstein R., Gronvik K.O. Cross-protection of chicken immunoglobulin Y antibodies against H5N1 and H1N1 viruses passively administered in mice. Clin. Vaccine Immunol. 2011, 18:1083-1090.
33. Wen J., Zhao S., He D., Yang Y., Li Y., Zhu S. Preparation and characterization of egg yolk immunoglobulin Y specific to influenza B virus. Antiviral Res. 2012, 93:154-159.
34. Widdowson M.A., Steele D., Vojdani J., Wecker J., Parashar U. Global rotavirus surveillance. determining the need and measuring the impact of rotavirus vaccines. J. Infect. Dis. 2009, 200(Suppl 1):S1-S8.
35. Xia M., Tan M., Wei C., Zhong W., Wang L., McNeal M., Jiang X. A candidate dual vaccine against influenza and noroviruses. Vaccine 2011, 29:7670-7677.
36. Zhang X.F., Dai Y.C., Zhong W., Tan M., Lv Z.P., Zhou Y.C., Jiang X. Tannic acid inhibited norovirus binding to HBGA receptors, a study of 50 Chinese medicinal herbs. Bioorg. Med. Chem. 2012, 20:1616-1623.